Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Humulin R

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 1/2 (1)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT03915613Phase 1/2Unknown

Brain Insulin Resistance in Mood Disorders

NCT02758691Phase 1Completed

fMRI Study of Effects of Nasal Insulin on Memory

Showing all 2 trials

Research Network

Common Treatments

  • Humulin R1
  • Diluent1
  • Insulin1

Active Sponsors

  • Virginia Polytechnic Institute and State University1
  • University Health Network, Toronto1

Related Conditions

  • Bipolar Disorder1
  • Anhedonia1
  • Major Depressive Disorder1
  • Human Memory1

Activity Timeline